From professional translators, enterprises, web pages and freely available translation repositories.
imikvimoodi).
5 mg imiquimod).
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
100 mg kreemi sisaldab 5 mg imikvimoodi
100 mg cream contains 5 mg imiquimod
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
100 mg kreemi sisaldab 5 mg imikvimoodi.
100 mg of cream contains 5 mg of imiquimod.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
imikvimoodi ei soovitata kasutada pediaatrilistel patsientidel.
use in the paediatric patient population is not recommended.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
1 gramm kreemi sisaldab 37,5 mg imikvimoodi
each gram of cream contains 37.5 mg of imiquimod.
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
aldara on kreem, mis sisaldab toimeainena imikvimoodi.
aldara is a cream containing the active substance imiquimod.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
zyclara 3,75% kreem sisaldab toimeainena imikvimoodi.
zyclara 3.75% cream contains the active substance imiquimod.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
imikvimoodi kasutamise kohta raseduse ajal ei ole kliinilisi andmeid.
for imiquimod no clinical data on exposed pregnancies are available.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
imikvimoodi kasutamisest pediaatrilistel patsientidel tõsiste kõrvaltoimete esinemisest tõendid puuduvad.
there was no evidence for serious adverse reaction caused by imiquimod in paediatric patients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
iga kotike sisaldab 12,5 mg imikvimoodi 250 mg kreemis (5%).
each sachet contains 12.5 mg of imiquimod in 250 mg cream (5 %).
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
seda turustatakse 250 mg kotikestena, mis sisaldavad 12,5 mg imikvimoodi (5%).
it is available as 250 mg sachets, each containing 12.5 mg imiquimod (5%).
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
iga kotike sisaldab 250 mg kreemi (100 mg kreemi sisaldab 5 mg imikvimoodi).
each sachet contains 250 mg cream (100 mg cream contains 5 mg imiquimod).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
küllastuva sideme uuringud näitavad, et reageerivates immuunrakkudes on olemas imikvimoodi jaoks membraani retseptor.
saturable binding studies suggest a membrane receptor for imiquimod exists on responding immune cells.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
imikvimoodi kandmisel nahale avaldab see immuunsüsteemile paikset toimet, vallandades tsütokiinide, sealhulgas interferooni vabanemise.
when imiquimod is applied to the skin, it acts locally on the immune system to trigger the release of cytokines, including interferon.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
imikvimoodi ei ole hinnatud aktiiniliste keratooside ravimiseks laugudel, sõõrmetes või kõrvades ega huulte huulepunapiirist sissepoole jääval alal.
imiquimod has not been evaluated for the treatment of actinic keratoses on the eyelids, the inside of the nostrils or ears, or the lip area inside the vermilion border.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
iga kotike sisaldab 9,375 mg imikvimoodi 250 mg kreemis (100 mg kreemi sisaldab 3,75 mg imikvimoodi.
each sachet contains 9.375 mg of imiquimod in 250 mg cream (100 mg of cream contains 3.75 mg imiquimod).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
raskete lokaalsete nahareaktsioonide oht võib suureneda imikvimoodi kasutamisel soovitatust suuremates annustes (vt lõik 4.2).
the risk of severe local skin reactions may be increased when imiquimod is used at higher than recommended doses (see section 4.2).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
pediaatrilistel patsiendidel on uuritud imikvimoodi farmakokineetilisi omadusi pärast ühe ja mitmekordset paikset manustamist kontagioosse molluski (km) korral.
the pharmacokinetic properties of imiquimod following single and multiple topical application in paediatric patients with molluscum contagiosum (mc) have been investigated.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
imikvimoodi toimet uuriti pediaatrilistel patsientidel kontrollitud kliinilistes uuringutes ( vt. lõigud 4.2 ja 5.1).
imiquimod was investigated in controlled clinical studies with paediatric patients (see sections 4.2 and 5.1).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
aldarat ei tohi kasutada patsiendid, kes võivad olla imikvimoodi või selle ravimi mis tahes muu koostisaine suhtes ülitundlikud (allergilised).
aldara should not be used in people who may be hypersensitive (allergic) to imiquimod or any of the other ingredients.
Last Update: 2017-04-26
Usage Frequency: 3
Quality: